1. Home
  2. AZTR vs APDN Comparison

AZTR vs APDN Comparison

Compare AZTR & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • APDN
  • Stock Information
  • Founded
  • AZTR 2014
  • APDN 1983
  • Country
  • AZTR United States
  • APDN United States
  • Employees
  • AZTR N/A
  • APDN N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • APDN Other Consumer Services
  • Sector
  • AZTR Health Care
  • APDN Consumer Discretionary
  • Exchange
  • AZTR Nasdaq
  • APDN Nasdaq
  • Market Cap
  • AZTR 4.2M
  • APDN 3.8M
  • IPO Year
  • AZTR 2023
  • APDN N/A
  • Fundamental
  • Price
  • AZTR $0.73
  • APDN $5.62
  • Analyst Decision
  • AZTR Strong Buy
  • APDN
  • Analyst Count
  • AZTR 1
  • APDN 0
  • Target Price
  • AZTR $4.00
  • APDN N/A
  • AVG Volume (30 Days)
  • AZTR 158.2K
  • APDN 1.2M
  • Earning Date
  • AZTR 11-11-2025
  • APDN 08-26-2025
  • Dividend Yield
  • AZTR N/A
  • APDN N/A
  • EPS Growth
  • AZTR N/A
  • APDN N/A
  • EPS
  • AZTR N/A
  • APDN 211.51
  • Revenue
  • AZTR N/A
  • APDN $3,743,063.00
  • Revenue This Year
  • AZTR N/A
  • APDN $57.08
  • Revenue Next Year
  • AZTR N/A
  • APDN $40.00
  • P/E Ratio
  • AZTR N/A
  • APDN $0.02
  • Revenue Growth
  • AZTR N/A
  • APDN 55.60
  • 52 Week Low
  • AZTR $0.68
  • APDN $2.13
  • 52 Week High
  • AZTR $4.33
  • APDN $327.32
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 50.75
  • APDN 67.97
  • Support Level
  • AZTR $0.68
  • APDN $2.80
  • Resistance Level
  • AZTR $0.79
  • APDN $4.74
  • Average True Range (ATR)
  • AZTR 0.04
  • APDN 0.73
  • MACD
  • AZTR -0.02
  • APDN 0.26
  • Stochastic Oscillator
  • AZTR 40.21
  • APDN 64.83

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About APDN Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Share on Social Networks: